Skip to content

Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas

Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07015645
Enrollment
137
Registered
2025-06-11
Start date
2019-01-01
Completion date
2025-01-01
Last updated
2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long Term, Hypopituitarism, Gamma Knife Radiosurgery, Pituitary Adenomas

Brief summary

This study aims to assess long-term outcomes of hypopituitarism following gamma knife radiosurgery (GKRS) for pituitary adenomas.

Detailed description

Pituitary adenomas (PAs) are one of the most common intracranial neoplasms, accounting for 10-20% of diagnosed brain tumors. Initial gamma knife radiosurgery (GKRS) can be an alternative treatment for selected NFPA patients with comorbidities, documented growth small tumors, cavernous sinus invasion, or advanced age. Hypopituitarism is one of the most common complications of radiosurgery (Cordeiro et al., 2018). Long-term follow-up is crucial to assess new pituitary deficits. Typically, hypopituitarism presents within the first 2-4 years after the treatment with radiosurgery, but the risk of pituitary insufficiency increases to up to 80%. Reports on the highest incidence of new-onset hypopituitarism also mentioned the longest follow-up period.

Interventions

Patients received gamma knife radiosurgery (GKRS) treatment for pituitary adenomas.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years. * Both sexes. * Patients treated with gamma knife radiosurgery (GKRS).

Exclusion criteria

* Patients with inadequate endocrine follow-up (\<12 months). * Patients who had undergone previous radiation therapy. * Pituitary insufficiency which presents before gamma knife radiosurgery (GKRS). * Patients without visible glands.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of new-onset hypopituitarism5 years post-procedurePrevalence of new-onset hypopituitarism will be recorded.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026